tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
XERS
Xeris Pharmaceuticals
RESEARCH TOOLSreports
Want to see XERS full AI Analyst Report?

Xeris Pharmaceuticals (XERS) Revenue

1,099 Followers
StatisticsMarket CapRevenue

Xeris Pharmaceuticals Revenue

Xeris Pharmaceuticals had a revenue of 83.13M in the quarter ending Mar 31, 2026, with -3.12%. This bring the company's revenue in the last twelve months to 314.85M, Decreased 7.88%. In the fiscal year ending Dec 31, 2025, Xeris Pharmaceuticals had annual revenue of 291.85M with 43.72% growth.
Revenue (ttm)
314.85M
Revenue Growth
41.47%
P/S Ratio
3.70
Revenue/Employee
$740,723
Employees
394
Market Cap
$1.08B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
291.85M88.78M+43.72%
Dec 31, 2024
203.07M39.16M+23.89%
Dec 31, 2023
163.91M53.67M+48.68%
Dec 31, 2022
110.25M60.66M+122.32%
Dec 31, 2021
49.59M29.16M+142.67%
Dec 31, 2020
20.43M17.71M+650.73%
Dec 31, 2019
2.72M257.00K+10.43%
Dec 31, 2018
2.46M909.00K+58.42%
Dec 31, 2017
1.56M――